Literature DB >> 17984063

Overexpression of wild-type androgen receptor in muscle recapitulates polyglutamine disease.

Douglas Ashley Monks1, Jamie A Johansen, Kaiguo Mo, Pengcheng Rao, Bryn Eagleson, Zhigang Yu, Andrew P Lieberman, S Marc Breedlove, Cynthia L Jordan.   

Abstract

We created transgenic mice that overexpress WT androgen receptor (AR) exclusively in their skeletal muscle fibers. Unexpectedly, these mice display androgen-dependent muscle weakness and early death, show changes in muscle morphology and gene expression consistent with neurogenic atrophy, and exhibit a loss of motor axons. These features reproduce those seen in models of Kennedy disease, a polyglutamine expansion disorder caused by a CAG repeat expansion in the AR gene. These findings demonstrate that toxicity in skeletal muscles is sufficient to cause motoneuron disease and indicate that overexpression of the WT AR can exert toxicity comparable with the polyglutamine expanded protein. This model has two clear implications for Kennedy disease: (i) mechanisms affecting AR gene expression may cause neuromuscular symptoms similar to those of Kennedy disease and (ii) therapeutic approaches targeting skeletal muscle may provide effective treatments for this disease.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17984063      PMCID: PMC2084330          DOI: 10.1073/pnas.0705501104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Gene targeting restricted to mouse striated muscle lineage.

Authors:  P Miniou; D Tiziano; T Frugier; N Roblot; M Le Meur; J Melki
Journal:  Nucleic Acids Res       Date:  1999-10-01       Impact factor: 16.971

2.  Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy.

Authors:  A R La Spada; E M Wilson; D B Lubahn; A E Harding; K H Fischbeck
Journal:  Nature       Date:  1991-07-04       Impact factor: 49.962

3.  Anabolic responsiveness of skeletal muscles correlates with androgen receptor protein but not mRNA.

Authors:  Douglas A Monks; Will Kopachik; S Marc Breedlove; Cynthia L Jordan
Journal:  Can J Physiol Pharmacol       Date:  2006-02       Impact factor: 2.273

4.  Effects of experimental type 1 diabetes and exercise training on angiogenic gene expression and capillarization in skeletal muscle.

Authors:  Riikka Kivelä; Mika Silvennoinen; Anna-Maria Touvra; T Maarit Lehti; Heikki Kainulainen; Veikko Vihko
Journal:  FASEB J       Date:  2006-07       Impact factor: 5.191

5.  Quantitative motor assessment in FALS mice: a longitudinal study.

Authors:  P Barnéoud; J Lolivier; D J Sanger; B Scatton; P Moser
Journal:  Neuroreport       Date:  1997-09-08       Impact factor: 1.837

6.  A frameshift mutation destabilizes androgen receptor messenger RNA in the Tfm mouse.

Authors:  N J Charest; Z X Zhou; D B Lubahn; K L Olsen; E M Wilson; F S French
Journal:  Mol Endocrinol       Date:  1991-04

7.  The AXH domain of Ataxin-1 mediates neurodegeneration through its interaction with Gfi-1/Senseless proteins.

Authors:  Hiroshi Tsuda; Hamed Jafar-Nejad; Akash J Patel; Yaling Sun; Hung-Kai Chen; Matthew F Rose; Koen J T Venken; Juan Botas; Harry T Orr; Hugo J Bellen; Huda Y Zoghbi
Journal:  Cell       Date:  2005-08-26       Impact factor: 41.582

8.  Time course of changes in angiogenesis-related factors in denervated muscle.

Authors:  A Wagatsuma; T Osawa
Journal:  Acta Physiol (Oxf)       Date:  2006-08       Impact factor: 6.311

9.  Progressive abnormalities in skeletal muscle and neuromuscular junctions of transgenic mice expressing the Huntington's disease mutation.

Authors:  Richard R Ribchester; Derek Thomson; Nigel I Wood; Tim Hinks; Thomas H Gillingwater; Thomas M Wishart; Felipe A Court; A Jennifer Morton
Journal:  Eur J Neurosci       Date:  2004-12       Impact factor: 3.386

10.  Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF.

Authors:  San Pun; Alexandre Ferrão Santos; Smita Saxena; Lan Xu; Pico Caroni
Journal:  Nat Neurosci       Date:  2006-02-12       Impact factor: 24.884

View more
  90 in total

1.  Native functions of the androgen receptor are essential to pathogenesis in a Drosophila model of spinobulbar muscular atrophy.

Authors:  Natalia B Nedelsky; Maria Pennuto; Rebecca B Smith; Isabella Palazzolo; Jennifer Moore; Zhiping Nie; Geoffrey Neale; J Paul Taylor
Journal:  Neuron       Date:  2010-09-23       Impact factor: 17.173

2.  Contractile dysfunction in muscle may underlie androgen-dependent motor dysfunction in spinal bulbar muscular atrophy.

Authors:  Kentaro Oki; Katherine Halievski; Laura Vicente; Youfen Xu; Donald Zeolla; Jessica Poort; Masahisa Katsuno; Hiroaki Adachi; Gen Sobue; Robert W Wiseman; S Marc Breedlove; Cynthia L Jordan
Journal:  J Appl Physiol (1985)       Date:  2015-02-05

Review 3.  Genetic approaches to the treatment of inherited neuromuscular diseases.

Authors:  Bhavya Ravi; Anthony Antonellis; Charlotte J Sumner; Andrew P Lieberman
Journal:  Hum Mol Genet       Date:  2019-10-01       Impact factor: 6.150

4.  Recovery of function in a myogenic mouse model of spinal bulbar muscular atrophy.

Authors:  Jamie A Johansen; Zhigang Yu; Kaiguo Mo; D Ashley Monks; Andrew P Lieberman; S Marc Breedlove; Cynthia L Jordan
Journal:  Neurobiol Dis       Date:  2008-12-31       Impact factor: 5.996

5.  Sexual differentiation of the spinal nucleus of the bulbocavernosus is not mediated solely by androgen receptors in muscle fibers.

Authors:  Lee Niel; Amit H Shah; Gareth A Lewis; Kaiguo Mo; Diptendu Chatterjee; Shannon M Fernando; Mei Hua Hong; William Y Chang; Peter Vollmayr; Jon Rosen; Jeffrey N Miner; D Ashley Monks
Journal:  Endocrinology       Date:  2009-03-12       Impact factor: 4.736

6.  A tetracycline-inducible and skeletal muscle-specific Cre recombinase transgenic mouse.

Authors:  Pengcheng Rao; D Ashley Monks
Journal:  Dev Neurobiol       Date:  2009-05       Impact factor: 3.964

Review 7.  Pathogenic mechanisms and therapeutic strategies in spinobulbar muscular atrophy.

Authors:  Jason P Chua; Andrew P Lieberman
Journal:  CNS Neurol Disord Drug Targets       Date:  2013-12       Impact factor: 4.388

8.  The androgen receptor's CAG/glutamine tract in mouse models of neurological disease and cancer.

Authors:  Andrew P Lieberman; Diane M Robins
Journal:  J Alzheimers Dis       Date:  2008-06       Impact factor: 4.472

Review 9.  The organizational-activational hypothesis as the foundation for a unified theory of sexual differentiation of all mammalian tissues.

Authors:  Arthur P Arnold
Journal:  Horm Behav       Date:  2009-05       Impact factor: 3.587

Review 10.  In Vitro and In Vivo Modeling of Spinal and Bulbar Muscular Atrophy.

Authors:  Maria Pennuto; Manuela Basso
Journal:  J Mol Neurosci       Date:  2015-11-27       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.